全球治療性血漿置換市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計治療性血漿置換市場將從 2025 年的 26 億美元成長到 2034 年的 50.9 億美元，2026 年至 2034 年的複合年成長率為 7.76%。

由於自體免疫疾病、神經系統疾病和血液系統疾病的盛行率不斷上升，全球治療性血漿置換市場正經歷穩定成長。重症肌無力、Guillain-Barré二氏症候群和血栓性血小板低下紫斑症疾病正在推動對血漿置換的需求。人們對先進血液淨化療法及其在治療複雜免疫相關疾病方面的有效性的認知不斷提高，這促進了這些療法在全球醫院和專科醫療中心的廣泛應用。

血液分離系統的技術進步是推動市場成長要素。最新的設備具有更高的安全性和效率、更短的治療時間，並能提升患者的舒適度和臨床療效。此外，已開發國家老年人口的成長、醫療費用支出的增加以及報銷政策的改善也促進了市場擴張。醫院正在加大對先進重症監護技術的投資，以增強其治療能力。

展望未來，免疫介導疾病領域臨床應用的拓展和持續的研究預計將對市場產生積極影響。新興經濟體醫療基礎設施的完善以及醫療專業人員意識提升也將創造更多機會。憑藉持續的技術創新和以患者為中心的治療方法，治療性血漿置換市場預計將在未來幾年實現穩定且永續的成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球治療性血漿置換市場：依適應症分類

• 市場分析、洞察與預測
• 神經系統疾病
• 腎臟疾病
• 血液疾病
• 其他

第5章：全球治療性血漿置換市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院
• 專科診所
• 門診手術中心

第6章：全球治療性血漿置換市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第7章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第8章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Asahi Kasei Corporation
  • Baxter International Inc
  • Terumo Corporation
  • B. Braun SE
  • Fresenius Kabi AG
  • SB-Kawasumi Laboratories Inc
  • Haemonetics Corporation
  • Cerus Corporation
  • Charles River Laboratories
  • Medica SPA

The Therapeutic Plasma Exchange Market size is expected to reach USD 5.09 Billion in 2034 from USD 2.60 Billion (2025) growing at a CAGR of 7.76% during 2026-2034.

The global therapeutic plasma exchange market is witnessing stable growth due to the increasing prevalence of autoimmune, neurological, and hematological disorders. Conditions such as myasthenia gravis, Guillain-Barre syndrome, and thrombotic thrombocytopenic purpura are driving demand for plasma exchange procedures. Growing awareness about advanced blood purification therapies and their effectiveness in managing complex immune-related diseases is supporting wider adoption across hospitals and specialty care centers worldwide.

Technological advancements in apheresis systems are a major growth driver for the market. Modern devices offer improved safety, efficiency, and reduced procedure time, enhancing patient comfort and clinical outcomes. Additionally, the rising geriatric population, increasing healthcare expenditure, and improved reimbursement policies in developed countries are contributing to market expansion. Hospitals are increasingly investing in advanced critical care technologies to strengthen treatment capabilities.

Looking ahead, the market is expected to benefit from expanding clinical applications and ongoing research in immune-mediated diseases. Growing healthcare infrastructure in emerging economies and rising awareness among healthcare professionals will further create opportunities. With continuous innovation and increasing focus on patient-centered treatment approaches, the therapeutic plasma exchange market is projected to experience steady and sustainable growth in the coming years.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Disease Indication

• Neurological Disorders
• Renal Disorders
• Hematology Disorders
• Others

By End-user

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers

COMPANIES PROFILED

• Asahi Kasei Corporation, Baxter International Inc, Terumo Corporation, B Braun SE, Fresenius Kabi AG, SBKawasumi Laboratories Inc, Haemonetics Corporation, Cerus Corporation, Charles River Laboratories, Medica SpA
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET: BY DISEASE INDICATION 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Disease Indication
• 4.2. Neurological Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Renal Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Hematology Disorders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET: BY END-USER 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End-user
• 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Specialty Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL THERAPEUTIC PLASMA EXCHANGE MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Disease Indication
  • 6.2.2 By End-user
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Disease Indication
  • 6.3.2 By End-user
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Disease Indication
  • 6.4.2 By End-user
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Disease Indication
  • 6.5.2 By End-user
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Disease Indication
  • 6.6.2 By End-user
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL THERAPEUTIC PLASMA EXCHANGE INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Asahi Kasei Corporation
  • 8.2.2 Baxter International Inc
  • 8.2.3 Terumo Corporation
  • 8.2.4 B. Braun SE
  • 8.2.5 Fresenius Kabi AG
  • 8.2.6 SB-Kawasumi Laboratories Inc
  • 8.2.7 Haemonetics Corporation
  • 8.2.8 Cerus Corporation
  • 8.2.9 Charles River Laboratories
  • 8.2.10 Medica S.P.A